中度CKD与健康成人肠道磷吸收的放射性同位素示踪研究
本研究采用33P放射性示踪剂直接测定中度CKD患者与匹配健康成人在控制饮食下的肠道磷吸收。结果显示两组间 fractional 肠道磷吸收无差异(0.69 vs 0.62,P=0.52),24小时尿磷亦无差异,尽管CKD患者1,25D更低、iPTH和iFGF23更高。
要点
- 中度CKD患者肠道磷吸收分数与健康成人无显著差异。
- CKD患者1,25D降低但肠道磷吸收未见代偿性下降。
- 24小时尿磷与肠道磷吸收分数无显著相关。
核心结论
- 典型饮食摄入下,中度CKD患者肠道磷吸收与健康成人无差异,尽管血清1,25D更低。
研究设计与样本
- 8天控制饮食研究,前6天门诊、后2天住院,采用33P口服与静脉给药及系列血尿采样。
- 纳入8例中度CKD患者(eGFR 29-55 ml/min per 1.73 m2)与8例年龄、性别、种族匹配的健康成人。
主要发现
- 肠道磷吸收分数CKD组0.69 vs 健康组0.62,P=0.52。
- 24小时尿磷CKD组884 mg/d vs 健康组935 mg/d,P=0.70。
- 肠道磷吸收分数与24小时尿磷无显著相关。
- CKD患者血清iPTH和iFGF23更高、1,25D更低。
- 1,25D与肠道磷吸收分数的关系无统计学显著性。
临床怎么用
- 中度CKD患者即使1,25D降低,肠道磷吸收未见代偿性减少,支持关注磷负荷管理。
局限性
- 样本量小(CKD与健康各8例)。
- 仅评估典型饮食摄入,未覆盖不同磷摄入量或CKD严重程度。
- 肠道磷吸收与24小时尿磷的关系未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reducing intestinal phosphorus absorption is a cornerstone in CKD-MBD management. Yet, knowledge gaps include how CKD pathophysiology affects intestinal phosphorus absorption. In vivo rodent studies suggest that intestinal phosphorus absorption remains inappropriately normal in early-moderate CKD, despite declining 1,25-dihydroxyvitamin D (1,25D). We measured intestinal phosphorus absorption in patients with moderate CKD versus healthy adults using a direct radiotracer method. METHODS: Patients with CKD and healthy adults matched for age, sex, and race were enrolled in this 8-day controlled diet study: the first 6 days outpatient and the final 2 days inpatient. Oral and intravenous doses of 33P and serial blood and urine sampling determined intestinal phosphorus absorption during the final 2 days. Secondary outcomes included fasting biochemistries and 24-hour urine phosphorus (uP). RESULTS: In total, n=8 patients with CKD (eGFR=29-55 ml/min per 1.73 m2) and n=8 matched healthy controls completed the study. On a controlled diet, no difference in fractional intestinal phosphorus absorption was detected between patients with CKD and healthy adults (0.69 versus 0.62, respectively; P=0.52), and this was similar for 24-hour uP (884 versus 935 mg/d, respectively; P=0.70). Fractional intestinal phosphorus absorption was not significantly related to 24-hour uP. Patients with CKD had higher serum intact PTH and intact FGF23 and lower 1,25D. The relationship between 1,25D and fractional intestinal phosphorus absorption was not statistically significant. CONCLUSIONS: Intestinal phosphorus absorption with typical dietary intake did not differ in patients with moderate CKD compared with controls, despite lower serum 1,25D levels. In this setting, a relationship between 24-hour uP and fractional or absolute intestinal absorption was not evident. Further investigation is needed to determine what factors influence intestinal phosphorus absorption in CKD and the apparent lack of compensation by the intestine to limit phosphorus absorption in the face of declining kidney function and reduced 1,25D. Whether this is evident across a range of dietary phosphorus intakes, as well as CKD severity, also needs to be determined. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Phosphorus Absorption in Healthy Adults and in Patients with Moderate Chronic Kidney Disease, NCT03108222.
引用
- Stremke ER, Wiese GN, Moe SM, et al. Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer. J Am Soc Nephrol. 2021. PMID: 34244325. doi:10.1681/ASN.2020091340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。